Newsletter | December 3, 2025

12.03.25 -- The Moral Economics Of Precision Medicine

SPONSOR

Join us for this Cell & Gene Live when Erin Harris, Chief Editor of Cell & Gene welcomes Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences at Accenture, and Michael Blackton MBA, VP, Manufacturing and Supply at Ocugen to unpack what CGT developers need to know about efficient, compliant dual- or multi-modal manufacturing even when production is outsourced. Registration is free thanks to support from Ecolab Life Sciences.

FOCUS ON REGULATORY & COMPLIANCE

The Moral Economics Of Precision Medicine

The most complex and expensive drugs to develop often target terrible diseases that affect only a small number of people and will never reach blockbuster status.

What Does Annex 1 Mean For Cryovial Filling?

New sterile manufacturing rules require major changes to cryovial filling. Ensure compliance by adopting better "first-air" protection, minimizing human contact, and using 100% dose checks.

Demystifying CGT Studies In Australia And The Broader APAC Region

Though conducting your clinical trial in Australia may initially seem daunting, the benefits are ample. Australia is home to qualified CRO partners that will guide your CGT to regulatory success.

Measuring And Monitoring Environmental Surface Residues

Explore techniques like visual inspection and TOC sampling to assess surface residues as well as discover the benefits and challenges of these practical methods to achieve effective residue validation.

Sterility Testing: Isolator Solutions To Minimize Contamination Risk

Sterility testing is susceptible to contamination, resulting in costly false positives, batch failures, and production delays. Isolator technology offers a robust solution to mitigate these challenges.

Best Practices For PUPSIT Assembly Design And Operation

Navigate the complexities of PUPSIT with expert guidance. Discover best practices for assembly design, regulatory compliance, and troubleshooting common challenges in sterile filtration environments.

How To Get Products To Patients Faster With A Connected QMS

BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Assimilate how digital solutions streamlined their operations and improved regulatory efficiency.

Manufacturing IPC/QC Of Gene-Engineered HSCs

In-process and quality control ensure manufacturing of gene-engineered hematopoietic stem cells. See an engineering process that enhances production through viral transduction and integrated sampling pouches.

In-Line PAT Solutions For cGMP Environments

Learn how real-time monitoring and PAT platforms can streamline bioprocessing, reduce testing delays, and improve decision-making across upstream and downstream workflows.

Mycoplasma Testing Of Biopharmaceuticals And ATMP: Current Regulations And Challenges

Mycoplasma contamination poses a significant risk to biopharmaceutical products and patient safety. Delve into how implementing a NAT-based testing method can enhance quality control and efficiency.

REGULATORY & COMPLIANCE SOLUTIONS

Effective Nucleic Acid Removal In High-Salt, GMP Workflows - QIAGEN

Connect With Cell & Gene: